Ezaldin M. I. Abuheit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ezaldin M. I. Abuheit has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ali Mansour Ali Nobah
Department of Cardiology First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China
1 shared publication - Amr Mekky
Department of Gastroenterology and Hepatology, People’s Hospital of Zhengzhou University, and Henan Provincial People’s Hospital, Zhengzhou, Henan, 450003, China
1 shared publication Bin‐Bin Yan
Department of Gastroenterology and Hepatology People's Hospital of Zhengzhou University and Henan Provincial People's Hospital Zhengzhou Henan China
1 shared publicationBo‐Wei Liu
Department of Gastroenterology and Hepatology People's Hospital of Zhengzhou University and Henan Provincial People's Hospital Zhengzhou Henan China
1 shared publication- Chen Zhang
Department of Gastroenterology and Hepatology Anyang Municipal People's Hospital Anyang Henan China
1 shared publication - Hafiz Muhammad Sohail Sarwar
Department of Pediatrics The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China
1 shared publication
Latest Publications
- 1 January 2025
- Published by Wiley in Helicobacter
- Vol. 30 (1) , e70021
Global Prevalence of Helicobacter pylori Infection‐Associated Gastric Preneoplastic Lesions in Pediatric Patients: A Systematic Review and Meta‐Analysis
Background: Helicobacter pylori (H. pylori) is the major cause of gastric mucosal precancerous lesions in adulthood, but its impact on pediatric patients remains unclear. We aimed to investigate H. pylori‐induced gastric precancerous lesions in children and adolescents globally and analyze their influencing factors for related disease management and prevention.Materials and Methods: We conducted a comprehensive literature search in major databases to identify studies including pediatric patients with gastric precancerous lesions and H. pylori infection status. Prevalence rates were computed using random‐effects or fixed‐effect models. A stratified analysis was conducted based on location, age, universal health coverage (UHC), and publication time.Results: Among the 3359 relevant articles screened, 24 studies (7036 participants) met the inclusion criteria. The overall prevalence of precancerous lesions in H. pylori‐infected patients was 17.2%, in which atrophic gastritis (AG) and intestinal metaplasia (IM) were 13.5% and 3.6%, respectively. Precancerous lesion rates in infected individuals across different regions were as follows: Africa at 33.8% (AG: 32.6%), Latin America at 22.1% (AG: 17.9%, IM: 4.0%), Asia at 18.1% (AG: 12.4%, IM: 4.4%, Dysplasia: 1.2%), and Europe at 6.3% (AG: 4.3%, IM: 1.7%). Infected adolescents (> 10 years) exhibited a higher prevalence of precancerous lesions than younger children (≤ 10 years) at 14.2% (AG: 9.7%, IM: 2.9%) versus 3.4% (AG: 2.3%, IM: 1.1%), respectively. The prevalence of precancerous lesions in infected patients was higher in areas with low‐medium UHC compared with high UHC (24.0% vs. 12.5%).Conclusions: H. pylori infection causes significant gastric mucosal precancerous lesions in pediatric patients, representing a major concern for this population and a previously neglected area. Future in‐depth investigations and proper management for related disease prevention are warranted.Trial Registration: PROSPERO number: CRD42023424683
- 1 January 2025
- Published by Wiley in Helicobacter
- Vol. 30 (1) , e70021
Global Prevalence of Helicobacter pylori Infection‐Associated Gastric Preneoplastic Lesions in Pediatric Patients: A Systematic Review and Meta‐Analysis
Background: Helicobacter pylori (H. pylori) is the major cause of gastric mucosal precancerous lesions in adulthood, but its impact on pediatric patients remains unclear. We aimed to investigate H. pylori‐induced gastric precancerous lesions in children and adolescents globally and analyze their influencing factors for related disease management and prevention.Materials and Methods: We conducted a comprehensive literature search in major databases to identify studies including pediatric patients with gastric precancerous lesions and H. pylori infection status. Prevalence rates were computed using random‐effects or fixed‐effect models. A stratified analysis was conducted based on location, age, universal health coverage (UHC), and publication time.Results: Among the 3359 relevant articles screened, 24 studies (7036 participants) met the inclusion criteria. The overall prevalence of precancerous lesions in H. pylori‐infected patients was 17.2%, in which atrophic gastritis (AG) and intestinal metaplasia (IM) were 13.5% and 3.6%, respectively. Precancerous lesion rates in infected individuals across different regions were as follows: Africa at 33.8% (AG: 32.6%), Latin America at 22.1% (AG: 17.9%, IM: 4.0%), Asia at 18.1% (AG: 12.4%, IM: 4.4%, Dysplasia: 1.2%), and Europe at 6.3% (AG: 4.3%, IM: 1.7%). Infected adolescents (> 10 years) exhibited a higher prevalence of precancerous lesions than younger children (≤ 10 years) at 14.2% (AG: 9.7%, IM: 2.9%) versus 3.4% (AG: 2.3%, IM: 1.1%), respectively. The prevalence of precancerous lesions in infected patients was higher in areas with low‐medium UHC compared with high UHC (24.0% vs. 12.5%).Conclusions: H. pylori infection causes significant gastric mucosal precancerous lesions in pediatric patients, representing a major concern for this population and a previously neglected area. Future in‐depth investigations and proper management for related disease prevention are warranted.Trial Registration: PROSPERO number: CRD42023424683
- Open Access
- 20 June 2023
- Published by Wiley in Clinical Cardiology
- Vol. 46 (8) , 981-988
Clinical assessment of VSR site and size and its relation to the severity of heart failure in post‐myocardial infarction ventricular septal rupture patients
Background: Ventricular septal rupture (VSR) is a rare but well‐known mechanical consequence of an acute myocardial infarction (AMI). Even in the later stages of re‐perfusion therapy, the result of VSR remains poor. Our aim is to assess the site and size of VSR in relation to the severity of cardiac failure.Methods: From January 2016 to December 2022, a total of 71 patients with a diagnosis of post‐myocardial infarction VSR were admitted to the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Data records were retrospectively included in this registry. In all patients, clinical and echocardiographic data were gathered, and statistical analyses were performed.Results: A total of 71 consecutive patients (mean age: 66.27 ± 8.88 years); 50.7% male, 49.3% female, with (M:F) ratio of almost (1:1). Left ventricular ejection fraction (LVEF) was (48.55 ± 10.44%) on echocardiography, and apical VSR was the most common site (69.0%). Overall, the VSD site was strongly related to the VSD size (p = .016), LVEF (p = .012), AMI site (p = .001), and affected coronary vessel (p = .004). Prodromal angina (p = .041), intra‐aortic balloon pump (p = .002), affected coronary vessels (p = .020), pro‐BNP (p = .000), and LVEF (p = .017) were predictors of the severity of heart failure.Conclusions: Diabetes mellitus is a common risk factor for post‐myocardial infarction VSR. VSR site and size had no relation to the severity of heart failure. A presentation with prodromal angina predicted severe heart failure and a worse prognosis.
- 20 June 2023
- Published by Wiley in Clinical Cardiology
- Vol. 46 (8) , 981-988
Open AccessClinical assessment of VSR site and size and its relation to the severity of heart failure in post‐myocardial infarction ventricular septal rupture patients
Background: Ventricular septal rupture (VSR) is a rare but well‐known mechanical consequence of an acute myocardial infarction (AMI). Even in the later stages of re‐perfusion therapy, the result of VSR remains poor. Our aim is to assess the site and size of VSR in relation to the severity of cardiac failure.Methods: From January 2016 to December 2022, a total of 71 patients with a diagnosis of post‐myocardial infarction VSR were admitted to the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Data records were retrospectively included in this registry. In all patients, clinical and echocardiographic data were gathered, and statistical analyses were performed.Results: A total of 71 consecutive patients (mean age: 66.27 ± 8.88 years); 50.7% male, 49.3% female, with (M:F) ratio of almost (1:1). Left ventricular ejection fraction (LVEF) was (48.55 ± 10.44%) on echocardiography, and apical VSR was the most common site (69.0%). Overall, the VSD site was strongly related to the VSD size (p = .016), LVEF (p = .012), AMI site (p = .001), and affected coronary vessel (p = .004). Prodromal angina (p = .041), intra‐aortic balloon pump (p = .002), affected coronary vessels (p = .020), pro‐BNP (p = .000), and LVEF (p = .017) were predictors of the severity of heart failure.Conclusions: Diabetes mellitus is a common risk factor for post‐myocardial infarction VSR. VSR site and size had no relation to the severity of heart failure. A presentation with prodromal angina predicted severe heart failure and a worse prognosis.